Delivery Order SPE2DB22D2006-SPE2DB23FW1ZZ
Award Date 8/9/23
Potential Completion Date 8/10/23
Potential Value $7.9K
Federal Agency
Ultimate Awardee
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a $7,132 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 84 mg doses of SPRAVATO (esketamine) nasal spray. The order was placed under an existing prime vendor contract vehicle to supply pharmaceutical products and services to DLA and the Department of Defense. Performance will take place in Conshohocken, Pennsylvania from August 21-22, 2023. No subcontractors or set aside designations were identified. This order supports DLA's...
- The Defense Logistics Agency awarded Amerisourcebergen Drug Corporation a $10,162.71 firm fixed price delivery order contract to provide 4561535214 doses of 84 mg SPRAVATO dose packs. SPRAVATO is an esketamine nasal spray used to treat treatment-resistant depression and post-traumatic stress disorder. The place of performance is Amerisourcebergen's Conshohocken, Pennsylvania facility. The single day contract period is July 18 through July 19, 2023, indicating an urgent need to replenish DLA's...
- The Defense Logistics Agency awarded a $27,734 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 4561450730 units of 84 mg doses of SPRAVATO. SPRAVATO is an esketamine nasal spray indicated for treatment-resistant depression. Amerisourcebergen, a subsidiary of Amerisourcebergen Corporation, will deliver the doses to a location in Conshohocken, Pennsylvania by July 11, 2023 to support the Defense Logistics Agency's medical supply needs. No subcontractors or set aside...
- The Defense Logistics Agency awarded a $1,417.55 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 4561835820 SPRAVATO 56 MG DOSE PACK UDS. The prime contractor, Amerisourcebergen Drug Corporation, is headquartered in Conshohocken, Pennsylvania and will deliver the pharmaceutical products to the same location by August 17, 2023. This delivery order was issued against an existing DLA contract vehicle to supply SPRAVATO, an esketamine nasal spray used to treat...
- The Defense Logistics Agency awarded a $5,616.08 firm fixed price delivery order to AmerisourceBergen Drug Corp for SPRAVATO 84 mg dose pack UDS (unit dose packs) with a completion date of September 26, 2025. This non-set-aside competitive award was issued on September 25, 2025, with performance to occur at the contractor's facility in Conshohocken, Pennsylvania. SPRAVATO (esketamine) is a specialized nasal spray medication indicated for treatment-resistant depression, representing a critical...
- The Defense Logistics Agency awarded a delivery order valued at $7,852.37 to AmerisourceBergen Drug Corp for SPRAVATO 84 mg dose pack unit dose systems (UDS), with completion scheduled for November 14, 2025. This firm fixed price delivery order, awarded on November 13, 2025, represents a non-set-aside competitive award and will be fulfilled from the contractor's corporate office location in Conshohocken, Pennsylvania. SPRAVATO is a nasal spray formulation of esketamine indicated for...
- The Defense Logistics Agency awarded a $7,489.08 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 84 mg doses of SPRAVATO, to be delivered to a location in Conshohocken, Pennsylvania by October 25, 2023. SPRAVATO is a brand name drug used to treat treatment-resistant depression, and this contract provides doses of that drug to support the Defense Logistics Agency's medical supply program. No set-aside provision was specified for this award. Amerisourcebergen Drug...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Spravato 84 mg dose pack units of use, valued at $11,134.62 on October 24, 2025, with an ultimate completion date of October 27, 2025. This is a firm fixed price delivery order with no set-aside designation, meaning it was competitively awarded. The product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's...
- The Defense Logistics Agency issued a $35,746.56 delivery order to Amerisourcebergen Drug Corp on March 10, 2026, for SPRAVATO 84 mg dose pack UDS pharmaceutical supply. This delivery order is issued under the DLA Troop Support Medical IDC (SPE2DX), a $999,999,999 indefinite delivery contract running through December 2026 that provides global pharmaceutical support to military healthcare programs. Place of performance is Conshohocken, PA. The order has a firm fixed price structure with an...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $3,904.65 on May 27, 2025, for the supply of Spravato 84 mg dose pack unit dose systems (UDS). This is a firm fixed-price, non-set-aside contract with an ultimate completion date of May 28, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. Spravato is an FDA-approved nasal spray medication primarily used for treatment-resistant depression, making this a specialized...
- SPE2DB22D2006Indefinite Delivery Contract
- SPE2DB22D2006-SPE2DB23FW1ZZDelivery Order
The Defense Logistics Agency awarded a $7,878.74 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 4561756377 units of 84 mg doses of SPRAVATO. SPRAVATO is an esketamine nasal spray indicated for treatment-resistant depression. The place of performance will be Amerisourcebergen's facility located in Conshohocken, Pennsylvania. The delivery order was issued against an existing DLA pharmaceuticals contract vehicle and has a period of performance from August 9-10, 2023. No set aside designation or subcontractors were identified. This order supports the DLA's mission to provide pharmaceuticals and other medical supplies to the U.S. Department of Defense.
Generated 12/14/23, 11:18 PM
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $7.9k | 8/9/23 |